{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:13:00Z","timestamp":1778818380651,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["UAR 3556"],"award-info":[{"award-number":["UAR 3556"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006005","name":"Agence de la Biom\u00e9decine","doi-asserted-by":"publisher","award":["PL0032023"],"award-info":[{"award-number":["PL0032023"]}],"id":[{"id":"10.13039\/501100006005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006005","name":"Agence de la Biom\u00e9decine","doi-asserted-by":"publisher","award":["DOS0162058"],"award-info":[{"award-number":["DOS0162058"]}],"id":[{"id":"10.13039\/501100006005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["18-CE18-0024-02"],"award-info":[{"award-number":["18-CE18-0024-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0016-01"],"award-info":[{"award-number":["ANR-11-LABX-0016-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-INBS-04"],"award-info":[{"award-number":["ANR-10-INBS-04"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004100","name":"Labex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.10.057","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:09:27Z","timestamp":1761869367000},"page":"1024-1046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses"],"prefix":"10.1016","volume":"34","author":[{"given":"C\u00e9cile","family":"Bergua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghenima","family":"Ahmil-Boiteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure-H\u00e9l\u00e8ne","family":"Ouisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nad\u00e8ge","family":"Vimond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"S\u00e9razin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Dugast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Humeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apolline","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Tesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katleen","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Van Brempt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Collette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-0631","authenticated-orcid":false,"given":"Carole","family":"Guillonneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.057_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.10.057_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2013.10.016","article-title":"Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response","volume":"39","author":"Bailey-Bucktrout","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.10.057_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.057_bib5","doi-asserted-by":"crossref","first-page":"a015461","DOI":"10.1101\/cshperspect.a015461","article-title":"Effector Mechanisms of Rejection","volume":"3","author":"Moreau","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2025.10.057_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.10.057_bib7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/imt-2016-0049","article-title":"Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside","volume":"8","author":"Kuhn","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ymthe.2025.10.057_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90088","article-title":"Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells","volume":"2","author":"Picarda","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.10.057_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005287","article-title":"CD45RC Isoform Expression Identifies Functionally Distinct T Cell Subsets Differentially Distributed between Healthy Individuals and AAV Patients","volume":"4","author":"Ordonez","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.057_bib10","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/bloodadvances.2020001688","article-title":"Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease","volume":"4","author":"Boucault","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.10.057_bib11","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.4049\/jimmunol.173.5.3140","article-title":"Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat","volume":"173","author":"Xystrakis","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.172.6.1701","article-title":"OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset","volume":"172","author":"Powrie","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.10.057_bib13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2017.02014","article-title":"Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow\/\u2212 Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice","volume":"8","author":"B\u00e9zie","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib14","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2004-03-1214","article-title":"Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation","volume":"104","author":"Xystrakis","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.057_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/eji.200324528","article-title":"Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RC high but not the CD45RC low subset","volume":"34","author":"Xystrakis","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib16","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.3389\/fimmu.2019.02131","article-title":"Immunophenotype of a Rat Model of Duchenne\u2019s Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment","volume":"10","author":"Ouisse","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156507","article-title":"Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy syndrome","volume":"132","author":"Besnard","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.057_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2015-09-625343","article-title":"Influence of immunoglobulin isotype on therapeutic antibody function","volume":"127","author":"Beers","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.057_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1991.18","article-title":"OKT3 first-dose reaction: Association with T cell subsets and cytokine release","volume":"39","author":"Gaston","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.10.057_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2141.2007.06974.x","article-title":"Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of Fc\u03b3RIIIA\/CD16","volume":"140","author":"de Romeuf","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib21","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.1601473","article-title":"Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms","volume":"198","author":"Cleary","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0009-9120(93)90014-W","article-title":"The determination of plasma or serum sialic acid","volume":"26","author":"Crook","year":"1993","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymthe.2025.10.057_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2012.02.005","article-title":"The interactions of therapeutic antibodies with Fc receptors","volume":"143","author":"Albanesi","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ymthe.2025.10.057_bib24","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3389\/fimmu.2018.01941","article-title":"T Cell\/B Cell Collaboration and Autoimmunity: An Intimate Relationship","volume":"9","author":"Petersone","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.973813","article-title":"Boosting regulatory T cell function for the treatment of autoimmune diseases \u2013 That\u2019s only half the battle","volume":"13","author":"Schl\u00f6der","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib26","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.057_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/cts.12597","article-title":"Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies","volume":"12","author":"Leipold","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ymthe.2025.10.057_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2297450","article-title":"Antibodies to watch in 2024","volume":"16","author":"Crescioli","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.ymthe.2025.10.057_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0300985820948822","article-title":"Human CD34 + Hematopoietic Stem Cell\u2013Engrafted NSG Mice: Morphological and Immunophenotypic Features","volume":"58","author":"Bl\u00fcmich","year":"2021","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-009-9327-3","article-title":"B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis","volume":"30","author":"Thompson","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib31","first-page":"2052","article-title":"IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)","volume":"119","author":"Jones","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.057_bib32","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.2147\/DDDT.S97956","article-title":"Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations","volume":"10","author":"D\u00f6rr","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ymthe.2025.10.057_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.transproceed.2020.01.013","article-title":"Analysis of Immune Cell Repopulation After Anti-thymocyte Globulin Administration for Steroid-Resistant T-cell\u2013mediated Rejection","volume":"52","author":"Sim","year":"2020","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.ymthe.2025.10.057_bib34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3109\/14653249.2012.715243","article-title":"Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation","volume":"14","author":"Bosch","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2025.10.057_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0167-5699(88)91326-6","article-title":"Differential expression of the leucocyte-common antigen family","volume":"9","author":"Thomas","year":"1988","journal-title":"Immunol. Today"},{"key":"10.1016\/j.ymthe.2025.10.057_bib37","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/nbt1260","article-title":"Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor","volume":"24","author":"Cox","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib38","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1158\/0008-5472.CAN-04-4212","article-title":"Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering","volume":"65","author":"Schuster","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.057_bib39","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4161\/mabs.20577","article-title":"Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314","volume":"4","author":"Kircheis","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.ymthe.2025.10.057_bib40","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1172\/JCI119110","article-title":"Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a\/CD18 (LFA-1) on NK cells","volume":"98","author":"Wing","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.057_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-199701150-00020","article-title":"Role of polymorphic Fc receptor FcgRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3\/T cell receptor antibody (WT31)1","volume":"63","author":"Tax","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2025.10.057_bib42","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","article-title":"Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)","volume":"94","author":"Winkler","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.057_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.iy.12.040194.000505","article-title":"CD45: An Emerging Role as a Protein Tyrosine Phosphatase Required for Lymphocyte Activation and Development","volume":"12","author":"Trowbridge","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib45","doi-asserted-by":"crossref","first-page":"10138","DOI":"10.1073\/pnas.97.18.10138","article-title":"A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation","volume":"97","author":"Johnson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.057_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrd2804","article-title":"Glycosylation as a strategy to improve antibody-based therapeutics","volume":"8","author":"Jefferis","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.10.057_bib47","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"V\u00e9ly","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fimmu.2016.00545","article-title":"Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets","volume":"7","author":"Mace","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.057_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150434","article-title":"CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity","volume":"11","author":"Krzywinska","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.057_bib51","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1073\/pnas.0601851103","article-title":"Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production","volume":"103","author":"Hesslein","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.057_bib52","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ebiom.2015.08.021","article-title":"Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers","volume":"2","author":"Krzywinska","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2025.10.057_bib53","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood-2010-06-292219","article-title":"Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases","volume":"117","author":"Hesslein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.057_bib54","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI125916","article-title":"Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming","volume":"129","author":"Merino","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.057_bib55","series-title":"Methods in Enzymology","first-page":"431","article-title":"Flow cytometry-based assessment of direct-targeting anti-cancer antibody immune effector functions","author":"Miller","year":"2020"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:48:01Z","timestamp":1778816881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625009323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1525001625009323"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.057","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}